Helios raises $2.3M
Helios announced a Seed round of $2.3M on 18 November 2026. The company operates in HealthTech and is based in United States. It was founded by Omar Abudayyeh, Co-founder. Announced yesterday.
Founder
Omar Abudayyeh
Co-founder, Helios
Outreach angles
- -Omar Abudayyeh conducted pioneering CRISPR diagnostics research at Harvard and MIT with co-founder Jonathan Gootenberg.
- -Abudayyeh helped establish Sherlock Biosciences, which developed the first FDA-authorised CRISPR-based diagnostic test.
- -Helios came out of stealth in Boston with a waitlist for an at-home test measuring more than 1,000 blood proteins.
Signals
SeedYC BackedHealthcareB2CSecond-Time FounderProduct Launch
Round details
Company: Helios
Domain: myhelios.com
Amount: $2.3M
Stage: Seed
Industry: HealthTech
Country: United States
Announced: 18 November 2026
Other HealthTech raises
Recently funded in United States